Pscilly

Reviews of PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen

No reviews yet. Share the first one.

PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen by Psilera, Inc.

Investigational candidate being studied preclinically for frontotemporal dementia and alcohol use disorder. First-in-human testing is anticipated in 2027. Investigational; not for sale.

Guides about PSIL-006 – Non-hallucinogenic psilocybin derivative / neuroplastogen

Related news

Glossary: Psilocybin

More from Psilera, Inc.